Incorporation of Anticancer Drug into a Cu(II)-based Porous Metal-organic Framework: Drug Delivery and Inhibiting Human Cervical Cancer Cells

Jing Chen,Jian Huang,E-Mei Lu
2018-01-01
Latin american journal of pharmacy
Abstract:A new robust microporous Cu(II)-based metal-organic framework with the formula of [Cu-3(TCPB)(2)(H2O)(2)] center dot 8DMA (1, H3TCPB = 1,3,5-tri(4-carboxyphenoxy) benzene) has been successfully synthesized by a one pot solvothermal reaction of a flexible tricarboxylic acid ligand with Cu(NO3)(2) center dot 3H(2)O. The structure of 1 has been well studied by single-crystal X-ray diffraction analysis and further characterized by elemental analysis, powder X-ray diffraction (PXRD), and thermogravimetric (TG) analyses. The efficient encapsulation of an anticancer drug 5-fluorouracil (5-Fu) on the desolvated 1 (1a) was studied by both of the drug delivery experiments and grand canonical Monte Carlo (GCMC) simulation. Furthermore, in vitro anticancer activity of compounds 1 and 5-Fu loaded 1a were also evaluated using MTT assay.
What problem does this paper attempt to address?